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were used to investigate the aggregation propensity of the eye-lens protein gS-crystallin. The wild-type protein was investigated
along with the cataract-related G18V variant and the symmetry-related G106V variant. The MD simulations suggest that local
sequence differences result in dramatic differences in dynamics and hydration between these two apparently similar point muta-
tions. This finding is supported by the experimental measurements, which show that although both variants appear to be mostly
folded at room temperature, both display increased aggregation propensity. Although the disease-related G18V variant is not the
most strongly destabilized, it aggregates more readily than either the wild-type or the G106V variant. These results indicate that
gS-crystallin provides an excellent model system for investigating the role of dynamics and hydration in aggregation by locally
unfolded proteins.INTRODUCTIONUnderstanding protein aggregation is important not only in
the context of protein conformational diseases and func-
tional amyloids, but also as a fundamental biophysical
problem. Awide variety of proteins have been found to mis-
fold and form fibrils both in vitro and in vivo (1). The fact
that even extremely soluble proteins, such as lysozyme,
can fibrillize under certain solution conditions (2) or as
a consequence of disease-related point mutations (3) has
led to the hypothesis that amyloid fibrils represent a gener-
ally stable state of proteins. The formation of aggregates can
be a result of misfolding; however, aggregation need not
directly correlate with protein thermodynamic instability.
For example, several variants of the human prion protein
associated with disease phenotypes are not destabilized rela-
tive to the wild-type (WT) protein (4,5), and do not undergo
significant changes in overall structure (6) or dynamics (7).
Many proteins form aggregates from localized unfolding of
native monomers (8–12), as reviewed by Chiti and Dobson
(13). Local unfolding can promote aggregation either by
direct interaction between the unfolded portions or by
exposing residues that are normally protected from exposure
to the solvent. Interactions with the solvent influence both
the kinetics of aggregation (14) and the structures of the
aggregates formed (15,16). For proteins that exist at high
concentrations in their cellular milieu, protein-protein inter-
actions in both the native and partially unfolded states may
be equally important for maintaining solubility. Here, we
investigate the roles of thermodynamic instability and inter-
molecular interactions via the unfolding and aggregation
properties of the human eye lens protein gS-crystallin.Submitted October 1, 2010, and accepted for publicationDecember 6, 2010.
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0006-3495/11/01/0498/9 $2.00This protein and variants thereof provide an excellent model
system for investigating the relationships between pro-
tein misfolding, hydration, and dynamics because its
primary biological function is to remain soluble at high
concentration.
Crystallins, which are the major protein components of
the eye lens, are not crystalline, but instead form large
complexes that exhibit short-range order. This enables
packing at very high concentration (>400 mg/mL). Unlike
in most tissues, protein turnover is negligible in the eye
lens, and thus the crystallins must remain stable and soluble
for a lifetime. There are two types of crystallins: bg-crystal-
lins, which are primarily structural, and a-crystallins, which
have an additional function of binding to misfolded proteins
and preventing aggregation (17,18). Like the other structural
bg-crystallins, gS is a compact b-sheet protein consisting of
two double Greek key domains. Although they are not iden-
tical in sequence, the two domains are highly symmetric,
making this protein essentially a structural homodimer.
The two domains of human gS have different stabilities
(19) and stabilize each other via the interdomain interface
(20). Biophysical studies have shown that short-range
protein-protein interactions are responsible for the conti-
nuity of the refractive index (21) and that the bg-crystallins
exhibit attractive interactions despite their very low aggre-
gation propensity (22), implying a delicate balancing act
between attractive and repulsive interactions among the
crystallins. Intermolecular interactions clearly play an
important role in establishing the high concentration of
the proteins in the eye lens and thus its high refractive index.
A cataract is formed when high-molecular-weight crys-
tallin aggregates accumulate in the lens, rendering it opa-
que. Aggregation can be caused by misfolding, as in the
case of gD-crystallin and gC-crystallin, which have beendoi: 10.1016/j.bpj.2010.12.3691
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FIGURE 1 (a) Human gS-crystallin homology model based on the
murine gS NMR structure (35). The N- and C-terminal domains are shown
overlaid with the mutated residues highlighted. This view shows the highly
accessible positions of G18 and G106 and the symmetry of gS-crystallin
domains. (b) Structural overlay of a backbone alignment of the N- and
C-terminal domains of gS-crystallin. The backbone alignment between
the two domains has an RMSD of only 1.08 A˚. (c and d) Detail of the loops
containing G18 and G106, respectively, from a configuration of theWTMD
simulation. In both panels the Gly residues, the charged side chains in their
neighborhood, and backbone atoms for the rest of the residue are shown in
licorice representation. The backbone hydrogen-bond interactions are also
highlighted. (e and f) Configuration snapshot for the same regions of the
protein from the MD simulations of the G18Vand G106V variants, respec-
tively. In both variants, significant loss of secondary structure in the region
occurs, along with opening of each loop. In each case the hydrophobic
valine side chain is pointing out into solution because of unfavorable
contacts with nearby charged residues.
gS-Crystallin Aggregation 499shown to form amyloid fibers in vitro (23,24), or by disrup-
tion of intermolecular interactions, as in aged a-crystallins,
which lose their ability to bind and solubilize damaged
proteins (25). Recent advances in x-ray crystallography
(26,27), solid-state NMR (28–31), and optical spectroscopy
(32,33) have enabled investigators to obtain detailed struc-
tural models of many fibrillar systems. However, this level
of structural information is not yet available for gS-crystal-
lin aggregates. The high solubility of these proteins also
complicates structural analyses of gS-crystallin in its native
state, although a crystal structure has been solved for the
C-terminal domain (34). A solution-state NMR structure
of the highly homologous mouse protein (35) provides
a clear view of the monomer but does not address its supra-
molecular structure or aggregation behavior.
In the absence of a detailed structural model, one way
to separate the effects of folding and intermolecular
interactions on protein aggregation is to investigate variants
with reduced solubility or stability. Many different crystal-
lin mutations can cause autosomal-dominant cataracts of
diverse morphologies that affect the a- (36,37), b- (38),
and g- (39–43) crystallins. Investigating clinically discov-
ered mutations is a clear starting point; however, it is
essential to make use of site-directed mutagenesis to test
hypotheses about the molecular basis of protein solubility.
In this work, we used molecular dynamics (MD) simulations
and optical measurements to compare the WT protein with
its G18V variant, which is associated with early-onset cata-
ract (39), and the symmetry-related G106V variant. Our
simulated and experimental results demonstrate that these
two superficially similar mutations have quite different
effects on folding stability and solubility.
A structural model of human gS-crystallin (Fig. 1) pro-
vides a starting point for analyzing structural and dynamical
changes that may be induced by the mutations. The overall
fold and the positions of the mutated residues are shown in
Fig. 1 a. In Fig. 1 b, the two domains are overlaid, demon-
strating the similarity of their folds and validating the idea
that G18 and G106 occupy symmetry-related positions
on the two domains. The backbone alignment between the
two domains has a root mean-square deviation (RMSD) of
only 1.08 A˚. Residues G18 and G106 are located in
solvent-exposed loops on either side of the protein, with
backbone torsion angles that are only allowable for glycine
(the starting torsion angles are F ¼ 88.4,J ¼ –167.6 for
G18, and F ¼ 92.5 and J ¼ –164.5 for G106). Fig. 1, c
and d, show configuration snapshots of these loops taken
from the end of a 50 ns MD simulation. Fig. 1, e and f,
show how the same loops undergo disruptions in secondary
structure in the G18V and G106V variants.
Although localized loss of secondary structure is sug-
gested by the positions occupied by these glycine residues,
and is predicted by the MD simulations, it is also necessary
to consider the solubility impact of placing a highly hydro-
phobic residue in a solvent-exposed position. At pH 7,valine is one of the most hydrophobic residues (44). The
addition of hydrophobic side chains could provide addi-
tional attractive forces between crystallin monomers even
without major structural changes. The abnormal aggrega-
tion of the sickle cell variant of hemoglobin is caused by
just such a substitution: a glutamic acid to valine point muta-
tion on the surface (45). The variant hemoglobin forms
metastable clusters in solution (46). Formation of these clus-
ters depends on long-range interactions, as well as hydration
and solution conditions, and the resulting regions of high
protein density can provide nucleation sites for aggregation
based on local, protein-specific mechanisms (47). Given
the extremely high concentration of structural crystallins
in the lens, which is similar to the concentration of hemo-
globin in red blood cells, reduced solubility due to addi-
tional hydrophobic interactions is a plausible mechanismBiophysical Journal 100(2) 498–506
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aggregation results purely from local hydrophobic effects,
one would expect G18Vand G106V to have nearly identical
stability and solubility because the position of the added
valine side chain with respect to the protein and the solvent
is essentially equivalent. However, if the solubility impact of
the G18V variant is primarily due to local protein unfolding,
then G106V, which is the analogous mutation to the more
stable C-terminal domain, should have either the same or
a less disruptive effect on the thermodynamic stability of
the entire protein. A recent study showed that G18V is
less stable with respect to thermal denaturation (48), but it
did not address the contributions of other factors, such as
protein-protein interactions, dynamics, and hydration. Our
results from simulations and experimental data indicate
that aggregation in gS-crystallin is not mediated purely by
either thermal instability or the addition of hydrophobic
residues to the surface of the protein; rather, it is mediated
by a more complex mixture of changes in structure, dynam-
ics, and hydration that depend on the particular amino acid
sequences of each domain.MATERIALS AND METHODS
MD simulations
We constructed a model of human gS-crystallin with Swiss-Pdb Viewer
(49), using the solution structure of the mouse protein (35) (PDB ID
2A5M) as template (96% homology). The initial structure was placed in
the center of a 64 56 68 A˚3 box containing water molecules and a single
counterion to neutralize the protein charge. Water molecules that overlap-
ped with the protein were removed. The final system consisted of a single
protein chain, 5490 waters, and one sodium ion for a total of 20,681 atoms.
The systemwas subjected to three stages of energyminimization in which
harmonic restraints were placed on all heavy atoms with force constants of
10, 5, and 1 kcal/mol$A˚, respectively. Each stage consisted of 200 steps of
conjugate-gradient energy minimization. The minimization was followed
by two 100 ps MD runs at constant volume and a constant temperature of
300 K. Harmonic constraints were applied to the protein backbone heavy
atoms during the first of these two runs. The constant-volume simulation
was followed by a simulation at constant pressure (1 atm) and temperature
(300 K). The variants were generated from the equilibrated WT trajectory
(after 20 ns). The initial equilibration for the variant systems consisted of
64 steps of conjugate-gradient energy minimization followed by 20 ps of
MD at constant volume and temperature. Constant-pressure and -tempera-
ture simulations of all three systems (WT, G18V, and G106V) were run for
50 ns, and analyses were performed over the last 30 ns.
The MD trajectories were generated using the NAMD 2.7 software
package (50). The CHARMM22 force field (51) was used for the protein,
and the TIP3P model was used for water (52). The smooth particle mesh
Ewald method (53,54) was used to calculate the electrostatic interactions.
The short-range, real-space interactions were cut off at 11 A˚ by means of
a switching function. A reversible multiple time-step algorithm (55) was
used to integrate the equations of motion with time steps of 2 fs for electro-
static forces and short-range nonbonded forces, and 1 fs for bonded forces.
The SHAKE algorithm was used to hold all bond lengths involving
hydrogen atoms fixed. A Langevin dynamics scheme was used to control
temperature, and Nose-Hoover-Langevin pistons were used for pressure
control (56,57). The VMD 1.8.7 (58) and UCSF chimera (59) software
packages were used for visualization and analysis. The covariance analysis
was performed using the R (60) package bio3d (61).Biophysical Journal 100(2) 498–506Gene construction, expression, and purification
A plasmid containing the WT human gS-crystallin cDNA sequence was
purchased from OpenBiosystems (Huntsville, AL). Oligonucleotides were
purchased from Sigma-Aldrich (St. Louis, MO). The gS-crystallin gene
was amplified with primers containing flanking restriction sites for NcoI
and XhoI, an N-terminal 6x His tag, and a TEV cleavage sequence (EN-
LYFQG) with the N-terminal methionine of gS-crystallin replaced by the
final glycine in the cleavage sequence. The polymerase chain reaction
product was cloned into the pET28a(þ) vector (Novagen, Darmstadt,
Germany), and point mutant constructs were assembled using splice-over-
lap polymerase chain reaction to mutagenize the WT gene. gS was overex-
pressed in Rosetta (DE3) Escherichia coli using standard IPTG-induced
overexpression protocols at 37C (WT and G106V) or 16C (G18V). Cells
were allowed to grow for 5-6 h (WT and G106V) or 12–14 h (G18V) post-
induction. The cells were lysed by sonication and the cell debris was
removed by centrifugation. His-TEV-gS was purified on an Ni-NTA
column (Applied Biosystems, Foster City, CA) and cut with the use of
a His-tagged TEV protease (produced in-house). The TEV protease and
His tag were removed by a second application to an Ni-NTA column,
and the pure gS was collected in the column flow-through. gS was dialyzed
into 10 mM phosphate buffer, pH 6.9, for all experiments unless otherwise
stated.Circular dichroism
Purified gS was diluted to 0.125 mg/mL in a solution of 10 mM phosphate
buffer at pH 6.9 for acquisition of full circular dichroism (CD) spectra, and
to 0.25 mg/mL in a solution of 10 mM phosphate buffer, pH 6.9, 150 mM
NaCl, and 1 mM DTT for unfolding experiments. Measurements were
taken on a J-810 spectropolarimeter (JASCO, Easton, MD) equipped with
a thermal controller. For unfolding measurements, the sample was heated
at a rate of 2C/min. For thermal denaturation curves, the CD at 218 nm
was monitored and the curves were fit to a two-state equilibrium unfolding
model. The temperature lag due to slow equilibration time between the CD
thermal controller and the sample was measured with a thermocouple and
adjusted for in all thermal unfolding calculations.Fluorescence spectroscopy
Fluorescence measurements were made on gS-crystallin and variants at
a concentration of 0.25 mg/mL in 10 mM phosphate buffer, pH 6.9,
22C, unless otherwise stated. Absorption-emission fluorescence spectra
were obtained with an F4500 fluorescence spectrophotometer (Hitachi,
Tokyo, Japan).Dynamic light scattering
Dynamic light scattering (DLS) measurements were obtained with
a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) on WT and
both variants of gS at a concentration of 1.0 mg/mL in 10 mM phosphate
buffer (pH 6.9). At each temperature, the sample was allowed to equilibrate
for 2 min before measurements were obtained, after which scattering
measurements were performed in triplicate, resulting in a heating rate of
~0.5C every 5 min.RESULTS AND DISCUSSION
MD simulations predict differences in dynamics
and hydration
Atomistic MD simulations of each protein in solution were
carried out to gain insights into the structural and dynamical
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FIGURE 2 Ca RMSFs mapped onto the gS-crystallin homology model.
(a) WT. (b) G18V. (c) G106V. In both variants, changes in conformational
dynamics with respect to the WT are not limited to the region around the
mutations and are also found in the helices, connecting turns, and loops.
Compared with the WT protein, G18V shows diminished thermal fluctua-
tions in these regions. In contrast, G106Vappears to be more flexible over-
all, with increased fluctuations in both surface regions and the b-sheet core.
a b
gS-Crystallin Aggregation 501effects of the mutations. Upon thermal equilibration in the
10-ns timescale, the Ca RMSD from the initial configuration
levels off to ~2–3 A˚ in all systems (Fig. S3 in the Supporting
Material), validating the homology modeling. Both muta-
tions cause losses in secondary structure (Fig. S4), but
because of the sequence differences between the two
domains, the changes disrupt the fold in different ways. In
theWTprotein, residues 18 and 106 each represent the begin-
ning of a sharp turn connecting two strands comprising part
of the N- and C-terminal b-sheets, respectively (Fig. 1, a
and b). In both variants, addition of the bulky valine side
chain truncates the b-strand and enlarges the turn radius. In
the simulation of the G18V variant, the hydrophobic valine
side chain points away from the protein, due to its unfavor-
able interaction with the nearby charged residues E12 and
D13. In fact, the aspartic acid shifts toward the turn due to
a favorable electrostatic interaction with K14 (Fig. 1 e).
In the G106 variant, residues E100 and K101 turn toward
each other to form a salt bridge (Fig. 1 f). Although both vari-
ants display local secondary structure disruption resulting
from opening of the loop in the region of themutated residue,
consistent with reduced stability, the disruption of secondary
structure is comparable in both domains (Fig. S4).
An examination of the configurational dynamics of each
protein reveals significant differences. The introduction of
the mutations causes opposing effects in the protein back-
bone thermal fluctuations, as revealed by the Ca root mean-
square fluctuations (RMSFs) (Fig. 2) and covariance analysis
(see the Supporting Material). Overall, thermal fluctuations
are higher in the G106V protein than in the WT, and the
disease-related G18V variant appears to be more rigid than
the WT protein. Some of the observed thermal fluctuations
are common to all three proteins, including intradomain
correlations within turns and helical domains, and between
neighboring secondary structure elements. In addition, corre-
lations resulting from internal movements of the b-sheets are
present in the N-terminal but not the C-terminal domain. As
expected, the b-sheets are the most rigid regions in all cases
(Fig. 2). The larger thermal fluctuations within secondary
structure elements in the N-terminal domain are consistent
with the reported difference in thermodynamic stability
between the two domains (19).FIGURE 3 (a) CD spectra of the WT, G18V, and G106V crystallins at
a concentration of 0.125 mg/mL in a solution of 10 mM phosphate buffer
(pH 6.9) at 20C. All three display the negative ellipticity at 218 nm that
is indicative of b-sheet secondary structure and common to g-crystallins.
(b) Fluorescence emission spectra of WT, G106V, and G18V, 0.25 mg/mL
in 10 mM phosphate buffer pH 6.9 at 22C, collected on a Hitachi F4500
fluorescence spectrophotometer. Both the WT and the G106V variant
have a maximum at 326 nm, whereas in the G18V variant it is slightly
shifted to 332 nm. Both of these methods indicate little structural difference
between the WT and variant proteins at room temperature.Experiments show that both gS-crystallin
variants are folded and have b-sheet structure
at room temperature
Optical spectra were collected to assess potential differences
in structure among the WT and variant proteins. A com-
parison of the CD spectra of the WT, G18V, and G106V
crystallins at room temperature shows that all three are
folded with a minimum ellipticity at 218 nm, consistent
with a primarily b-sheet secondary structure (Fig. 3 a).
The spectra of the WT and G106V variants are nearly iden-
tical, whereas the 218 nm signal is slightly less intense in theG18V protein, possibly indicating minor disruption of the
b-sheet structure. Fluorescence spectra can provide a more
sensitive probe of local structural perturbations than CD,
which just addresses the overall fold. This should be partic-
ularly informative in g-crystallins, where fluorescence is
mediated by four highly conserved tryptophan residues in
the core of the protein (24). The specific positioning of
the tryptophan side chains has been found to be important
in rapid quenching of the UV fluorescence and may act asBiophysical Journal 100(2) 498–506
502 Brubaker et al.a UV filter protecting the retina (62,63); thus, large changes
in the positions and solvent exposure of these residues
should be readily observable in the UV fluorescence spectra.
The results for the WT and variant proteins are shown in
Fig. 3 b. The fluorescence emission maxima of the WT
and G106V spectra are at identical positions at 326 nm,
whereas the maximum is shifted slightly to 332 nm for
G18V. This red shift is consistent with slight unfolding to
partly expose tryptophan to the solvent, but overall the
structural differences between the WT and variant proteins
at room temperature appear to be minimal, consistent with
the MD simulations.The disease-related G18V variant is not the
least stable
The proteins appear structurally similar at room tempera-
ture; however, when we heat the protein while monitoring
the signal at 218 nm, interesting differences become
apparent. Although it is relatively insensitive to local
changes in protein conformation, the CD melting curve
provides information about the overall stability of the
protein fold. As shown in Fig. 4 a, the two mutations do
not have the same effect on protein stability, and the
disease-related variant is not the least stable. Unexpectedly,
the G106V variant unfolds far more readily than G18V. This
result indicates that there may be subtle structural changes
involving more of the protein than the small loop regions
containing G18 and G106. In addition, the fact that both
of these point mutations have such significant effects on
the thermodynamic stability of gS-crystallin indicates that
these glycines and the loops that rely on their dihedral
angles are critical for the stability of the crystallin fold.T (ºC)
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FIGURE 4 (a) Thermal unfolding curves of WT, G18V, and G106V crys-
tallins measured by monitoring the CD signal at 218 nm, with best-fit
unfolding curves. Unfolding measurements were obtained with a JASCO
J-810 spectropolarimeter equipped with a thermal controller. The protein
concentration was 0.25 mg/mL in the same buffer conditions as in Fig. 3 a,
but with 150 mM NaCl, and 1 mM DTT (reducing agent). Tm-values for
WT, G18V, and G106V are 72.0C, 65.6C, and 59.0C, respectively. All
three variants exhibit behavior consistent with two-state equilibrium un-
folding. (b) DLS measurement of thermally induced aggregation of WT,
G18V, G106V gS. Although the CD unfolding curves show G106V to be
the least thermodynamically stable, G18V is found to be the most aggrega-
tion-prone variant.
Biophysical Journal 100(2) 498–506Using nonlinear regression in Mathematica, we fit the CD
melting curves to a two-state equilibirum unfolding model
described by the following expression:
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The results of these measurements and their analysis are
shown in Fig. 4 a.
The WT protein had a Tm ¼ 72.0 5 0.1C, with
DH ¼ 161.2 5 6.1 kcal/mol, and DS ¼ 0.467 5
0.018 kcal mol1K1. The melting temperature for G18V
was depressed ~7, with Tm ¼ 65.6 5 0.1C, DH ¼
111.9 5 3.0 kcal/mol, and DS ¼ 0:33250:009 kcal
mol1 K1. The G106V mutation depressed the melting
temperature even further, to ~13 below WT, yielding
Tm ¼ 59.0 5 0.1C, DH ¼ 159:553:3kcal/mol, and
DS ¼ 0:48050:010 kcal mol1K1. The thermodynamic
melting temperatures for WT and G18V crystallins deter-
mined from the CD unfolding experiment are in agreement
with published values (19,48).The G18V variant aggregates more readily
than the WT or G106V
We measured aggregation in the WT and both variants
directly by DLS. The results are shown in Fig. 4 b. These
measurements were made at low salt concentration in the
absence of reducing agents to avoid interfering with any
relevant attractive intermolecular forces. We averaged the
% abundance by number of the three scans at each temper-
ature and fit the results to a Gaussian function using
nonlinear regression. In Fig. 4 b, the average particle size
is plotted as a function of temperature. The WT protein is
monomeric up to ~49.0C, where aggregates 30–50 nm in
diameter are formed. At this point, the solution still remains
optically clear with no visible light scattering. The estimated
diameter of these intermediate-size aggregates remains rela-
tively constant with increasing temperature until 58.5C.
Above 58.5C, the protein rapidly forms aggregates of up
to 1 mg in diameter. At 59–60C, these become the most
numerous aggregates, with virtually all of the observable
protein in this state at 60C. The G106V variant behaves
similarly to the WT, although its solubility is reduced, and
the transitions occur at lower (by 11–15C) temperatures.
Monomers are not observed in the G18V sample even
at the lowest temperatures investigated, and it seems to
gS-Crystallin Aggregation 503undergo only one transition, with the large particles appear-
ing at 49C and most of the protein is in this state at 50C.
Because the Fourier analysis used to estimate the particle
size assumes that particles are roughly spherical and may
weight the abundance incorrectly if the forming particles
are long fibrils, we observed the morphology of aggregated
gS-crystallin using scanning electron microscopy (SEM) to
confirm both the size and the morphology of the aggregates.
SEM images of the largest aggregates (formed at 70C) ap-
peared to be composed of interconnected strands of protein
roughly the diameter of the intermediate aggregates deter-
mined by DLS (Fig. S2). This supports the idea that the
crystallin protein has an intermediate stage of aggregation
during which it will stably form small particles of a consis-
tent size. A detailed comparison of intermediate aggregates
with fibers formed over a longer period of time is needed to
ascertain whether the aggregates undergo further conforma-
tional change to form amyloid fibers or remain as aggregates
of native-like proteins.
The higher critical aggregation temperatures (i.e., forma-
tion of large aggregates) in the DLS measurements are in
agreement with the Tm-values determined by CD, indicating
that this larger hydrodynamic radius state may be related
to protein unfolding, as the overall fold of G18V is more
stable than G106V. However, the lower critical aggregation
temperatures (i.e., formation of smaller aggregates) suggest
that G18V has a greater thermal aggregation propensity than
G106V in the absence of salt, because it forms particles of
intermediate size even below 20C. This result is surprising
given the similarity of the overall folds of the two domains
(Fig. 1 b). Previous thermodynamic studies on gS have
demonstrated that unfolding experiments require some
form of salt (either NaCl or GuCl) to keep the protein
soluble up to its thermodynamic unfolding temperature
(19,48). Results obtained by repeating the DLS measure-
ments on gS-WT in the presence of varying amounts of
salt indicate that the first aggregation may be shielded by
the presence of ions that can neutralize charged groups on
gS that are either exposed or separated during thermal
perturbation (Fig. S3). It is also possible that protein
dynamics play an important role in preventing undesirable
intermolecular interactions leading to the first stage of
aggregation. It is essential to understand the formation of
small aggregates, because these intermediate aggregates
are thought to be the toxic species in many protein deposi-
tion diseases (1,64). Dynamics, along with the avoidance
of too-similar surface residues that might form crystal
contacts, may be a target of selection pressure on this
protein, which has evolved to resist aggregation.MD simulations show a solvent-exposed cavity
in the N-terminal domain of G18V
The CD and UV fluorescence data obtained at room temper-
ature suggest that the addition of V18 or V106 to the foldedprotein does not unfold the whole Greek key domain; rather,
it acts by a more complicated mechanism. The simulations
show that G18V becomes more rigid, whereas G106V is
more mobile, consistent with its lowest thermodynamic
stability. However, the anomalously high aggregation pro-
pensity of G18V, in light of the lower thermodynamic
stability and higher mobility of G106V, appears to require
additional factors related to specific sequence differences.
This could involve exposing interior residues to the solvent,
or forcing a separation of charge in oppositely charged resi-
dues on adjacent loops. The distribution of charged residues
on gS is particularly interesting, given their abundance on
the surface of the protein despite its expected pI of 6.44,
and its high solubility while neutrally charged. It is possible
that the distribution and organization of charged surface
residues have been tuned to optimize the solubility of
gS-crystallin by controlling the hydration.
To quantify protein hydration in the MD simulation
trajectories, we computed the number density of waters in
the first coordination shell of the protein in a 1 A˚/point
grid, and identified grid points with a number density of at
least twice the bulk value as water sites (65). There is an
apparent inverse correlation between the number of water
sites and the total solvent-accessible surface area among
the three proteins, suggesting the presence of buried waters
in the clefts and crevices of the fold (Fig. S12). Consistent
with this idea, the largest population of water sites occurs
at the interfacial region between domains (Fig. 5 a) for all
three proteins. G18V exhibits the largest number of water
sites (Fig. S12), which are located in crevices on the surface
of the N-terminal domain that are not found in either the WT
or the G106Vmutant (Fig. 5 a). The formation of these crev-
ices in the G18V N-terminal domain can be traced back to
the salt-bridge interactions among the charged side chains
in the connecting segments between b-sheets, in particular
those involving D78. In the WT protein, D78 alternates
salt-bridge interactions with R79 or R36 (Fig. 5 b and
Fig. S13 a). Similarly, in G106V there is a persistent salt-
bridge interaction between D78 and R36 (Fig. S13 a).
In the G18V variant, this pattern is broken: the D78 and
R79 side chains are not correctly positioned to form a salt
bridge; rather, they form persistent salt bridges with residues
in the outer loops (Fig. 5 c and Fig. S13 a), and this new
distribution of salt-bridge interactions opens the crevices.
There is no analogous charged pair in the same connecting
loop of the C-terminal domain. There are a few unique salt-
bridge interactions in the C-terminal domain of the G106V
mutant (Fig. S13 b), but these are all between neighboring
residues, and their effect on the C-terminal hydration, with
respect to the WT, is negligible.
Hydration is an important parameter in the aggregation
behavior of proteins, and specifically bound or trapped
waters play structural and functional roles in many sys-
tems (66). Although the densely packed b-sheet structures
of amyloid fibrils are relatively dehydrated, previouslyBiophysical Journal 100(2) 498–506
G18
b
WT
D29
V18
c
WT
G106V
G18V
a
D29
R52D78
R79
R79
R36
D78
R36
R52
G18V
FIGURE 5 (a) Regions in the first coordination shell of the protein with
water density of twice the bulk value are highlighted. The region between
the two domains exhibits the largest number of water sites in all three
proteins. A significant number of water sites are also observed in the
N-terminal loop regions of the G18V variant. A configuration snapshot of
the WT protein is shown in secondary structure representation and as
a molecular surface. (b and c) Top view of the N-terminal domain in the
WT and G18V variant, respectively. The water isodensity surfaces (twice
bulk value) are shown in green (WT) and blue (G18V). Crevices are formed
in the protein surface of the G18V variant in the region of the mutation and
between the inner loops as a key charged pair (D78 and R79) form persis-
tent salt-bridges with residue located in the outer loops. In the WT, in
contrast, D78 alternates salt-bridge interactions with R79 and the neigh-
boring R36. In both panels the protein is shown in secondary structure
representation and the specific side chains are shown in CPK representation
colored by atom (carbon, gray; nitrogen, blue; oxygen, red; hydrogen,
white).
504 Brubaker et al.published two-dimensional infrared measurements suggest
that individual bound waters are present between b-strands
(15). In the fibril-forming peptide islet amyloid, organic
solvents have been shown to dramatically increase the
aggregation rate, presumably by altering hydrogen bonding
or stabilizing intermediate aggregates (67).CONCLUSIONS
In summary, the initial aggregation propensity in gS-crys-
tallin is not directly correlated with thermodynamic insta-
bility. This suggests that locally unfolded states are
responsible. If full unfolding were required for aggregation,
making the equivalent mutation and concomitant structural
perturbation to the more stable C-terminal domain shouldBiophysical Journal 100(2) 498–506result in a variant with both intermediate stability and solu-
bility. Instead, the results of this study indicate that although
the G106V variant is less thermodynamically stable, it is not
as aggregation-prone as the disease-related G18V variant.
These results establish that gS-crystallin and its aggrega-
tion-prone variants provide an excellent model system for
elucidating the structural and dynamic determinants of
protein solubility. Although further experiments and simula-
tions will be necessary to more fully characterize both the
intermediate and the final aggregates, and measure the
kinetics of aggregation, our study shows that in this system,
protein dynamics and hydration may be just as important as
stability. Equally important is the finding that apparently
similar point mutations have dramatically different effects
on the dynamics, hydration, and aggregation behavior of
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